Previous
Next

Creating Hope

Retrophin is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.

Creating Hope

Retrophin is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.

Creating Hope

Retrophin is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.

We are focused on advancing the development of our lead pipeline assets: sparsentan for FSGS, a serious kidney disorder that often leads to end-stage renal disease;1 and RE-024 for PKAN, a life-threatening neurological disorder that typically begins in early childhood.2

learn more

 

 

 

 

 

  1. Middleton, et al. Nephrology Rounds 2007; 5(4).
  2. Gregory, et al. GeneReviews. 2002.

Therapeutic Focus

Retrophin is a biopharmaceutical company focused on discovering, developing and marketing innovative therapies for debilitating and often life-threatening diseases.  We are dedicated to working in areas in which the biopharmaceutical industry has, to date, had limited interest or effectiveness.  We maintain a focus on patients, working with doctors and patient advocacy groups and seeking to understand their distinct needs.

Latest News